Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients

Strahlentherapie und Onkologie

Volumn 179, Issue 3, 2003, Pages 191-196

  Huh, Seung Jae ^a   Lim, Do Hoon ^a   Ahn, Yong Chan ^a   Lee, Jeong Eun ^a   Kang, Min Kyu ^a   Shin, Seong Soo ^a   Shin, Kyung Hwan ^a   Kim, Bokyung ^a   Park, Won ^a   Han, Youngyih ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cervix cancer; High dose rate brachytherapy; In vivo dosimetry; Rectal complications

Indexed keywords

BARIUM;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; FOLLOW UP; HIGH DOSE RATE INTRACAVITARY RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; RECTUM INJURY; STATISTICAL SIGNIFICANCE; THERMOLUMINESCENCE DOSIMETER; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BARIUM SULFATE; BRACHYTHERAPY; DOSE FRACTIONATION; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MIDDLE AGED; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RECTAL DISEASES; RECTUM; RETROSPECTIVE STUDIES; THERMOLUMINESCENT DOSIMETRY; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0037337007     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1015-2     Document Type: Article

References (31)

1. Budrukkar AN, Shrivastava SK, Jalali R, Agarwal JP, Deshpande DD, Nehru RM, Dinshaw KA. Transperineal low-dose rate iddium-192 interstitial brachytherapy in cervical carcinoma stage IIB. Strahlenther Onkol 2001;177:517-24.
2. Chassagne D, Sismondi P, Horiot JC, et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993;26:195-202.
3. Chatani M, Matayoshi Y, Masaki N, Teshima T, Inoue T. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results. Strahlenther Onkol 1994;170:636-42.
4. Choi P, Teo P, Foo W, O SK, Leung SF, Tsao SY, Shiu W. High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate. Clin Oncol 1992;4:186-91.
5. Clark BG, Souhami L, Roman TN, Evans MD, Pla C. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1994;28:1243-50.
6. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
7. Crook JM, Esche BA, Chaplain G, Isturiz J, Sentenac I, Horiot JC. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987;8:321-32.
8. Cunningham DE, Stryker JA, Velkley DE, Chung CK. Routine clinical estimation of rectal, rectosigmoidal, and bladder doses from intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1981;7:653-60.
9. Deshpande DD, Shrivastav SK, Pradhan AS, Viswanathan PS, Dinshaw KA. Dosimetry of intracavitary applications in carcinoma of the cervix: rectal dose analysis. Radiother Oncol 1997;42:163-6.
10. Dunst J, Haensgen G. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy. Strahlenther Onkol 2001;177:635-40.
11. Hall EJ. Radiobiology for the radiologist, 3rd edn. Philadelphia: Lippincott, 1998:107-36.
12. ICRU Report No. 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda: International Commission on Radiation Units and Measurements, 1985.
13. Ito H, Kutuki S, Nishiguchi I, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy correlation between tumor size, dose and failure. Radiother Oncol 1994;31:240-7.
14. Kapp KS, Stuecklschweiger GF, Kapp DS, Hackl AG. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol 1992;24:137-46.
15. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko O, Pickel H, Hackl A. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997;42:143-53.
16. Montana GS, Fowler WC. Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1989;16:95-100.
17. Ogino I, Kitamura T, Okamoto N, Yamasita K, Aikawa Y, Okajima H, Matsubara S. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 1995;31:725-34.
18. Orton CG, Wolf-Rosenblum S. Dose dependence of complication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:37-44.
19. Perez CA, Fox S, Lockett MA, et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 1991;21:885-98.
20. Potter R, Knocke TH. The potential of 3-D conformal brachytherapy and external beam radiotherapy in cervical cancer. Strahlenther Onkol 2001;177: 641-2, discussion 643-4.
21. Pourquier H, Dubois JB, Delard R. Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys 1982;8:1887-95.
22. Roman TN, Souhami L, Freeman CR, Pla C, Evans MD, Podgorsak EB, Mendelew K. High dose rate afterloading intracavitary therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1991;20:921-6.
23. Senkus-Konefka E, Kobierska A, Jassem J, Serkies K, Badzio A. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer. Strahlenther Onkol 1997;173:323-9.
24. Shin KH, Huh SJ, Chie EK, et al. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis. Radiat Med 1999;17:289-93.
25. Stryker JA, Bartholomew M, Velkley DE, Cunningham DE, Mortel, R, Craycraft G, Shafer J. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol 1988;29:1-11.
26. Teshima T, Chatani M, Hata K, Inoue T. High-dose rate intracavitary therapy for carcinoma of the uterine cervix: II. Risk factors for rectal complication. Int J Radiat Oncol Biol Phys 1988;14:281-6.
27. Tod MC, Meredith WJ. Treatment of cancer of the cervix uteri - a revised "Manchester method". Br J Radiol 1953;26:252-7.
28. Uno T, Itami J, Aruga M, et al. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications. Int J Radiat Oncol Biol Phys 1998;40:615-21.
29. Utley JF, Essen CF von, Horn RA, Moeller JH. High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1984;10:2259-63.
30. Van Lancker M, Storme G. Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications. Int J Radiat Oncol Biol Phys 1991;20:1125-9.
31. Wachter S, Gerstner N, Goldner G, Potzi R, Wambersie A, Potter R. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol 2000;54:11-9.